The FDA has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.

The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.

Representation of minority groups among neurology residency applicants grew from 2007 to 2020, but matriculants remain underrepresented.

Lewy body dementia is often misdiagnosed as Alzheimer disease, despite high specificity of clinical diagnosis.

One-third of congenital cytomegalovirus-related hearing loss would be missed without universal screening programs.

Overall rates of nicotine vaping declined among US youth, but those who continue to vape are showing signs of worsening addiction.

The Trump administration directed visa officers to consider chronic health conditions when deciding whether to approve entry into the US.

Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...

Anti-inflammatory diets during pregnancy are associated with better postpartum sleep quality among women with obesity prior to pregnancy.

Extreme longevity is linked to compressed cognitive decline and increased resilience to AD and vascular pathology.

HealthDay News — The U.S. Food and Drug Administration (FDA) is eliminating the prominent “black box” warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the ...

A new companion to the GSA KAER Toolkit for Brain Health helps clinicians and caregivers promote brain health, detect cognitive changes early, and support adults with intellectual and developmental ...